loading

Akero Therapeutics Inc Stock (AKRO) Forecast

The Akero Therapeutics Inc (AKRO) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $25.83, representing a -16.62% decrease from the current price of $30.98. The highest analyst price target is $34.28, and the lowest is $17.38.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AKRO Price Target
Average 26.37 (-14.89% Downside)
loading

Is Akero Therapeutics Inc (AKRO) A Buy Now?

Oscillators
Name Value Action
RSI(14) 49.29 Neutral
STOCH(9,6) 29.58 Neutral
STOCHRSI(14) 31.37 Neutral
MACD(12,26) 0.1344 Sell
ADX(14) 24.69 Neutral
William %R -59.77 Neutral
CCI(14) -50.28 Neutral
Buy: 0 Sell: 1 Neutral: 6
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
31.05
Sell
30.85
Sell
MA20
31.50
Sell
30.95
Sell
MA50
29.83
Buy
29.86
Buy
MA100
27.80
Buy
28.22
Buy
MA200
25.34
Buy
27.61
Buy
Buy: 6 Sell: 4 Neutral: 0
Summary: Buy
According to our latest analysis, AKRO could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on AKRO, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 49.29 indicates that AKRO is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 29.58 indicates that AKRO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.37 indicates that AKRO is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 24.69 suggests that there may be some movement in price, but it lacks strength or conviction.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -50.28 indicates that AKRO is still oversold but not to an extreme extent.

Long-term AKRO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Akero Therapeutics Inc financial reports and earnings history, Akero Therapeutics Inc (AKRO) stock could reach $30.95 by 2030, $50.02 by 2040 and $31.70 by 2050. See the projected annual prices until 2050 of the Akero Therapeutics Inc stock below:

  • Akero Therapeutics Inc (AKRO) is expected to reach an average price of $21.58 in 2035, with a high prediction of $24.98 and a low estimate of $20.73. This indicates an $-30.33% rise from the last recorded price of $30.98.
  • Akero Therapeutics Inc (AKRO) stock is projected to chart a bullish course in 2040, with an average price target of $47.52, representing an $53.40% surge from its current level. The forecast ranges from a conservative $42.79 to a sky-high $50.02.
  • Our analysts predict Akero Therapeutics Inc (AKRO) to jump 51.88% by 2045, soaring from $43.04 to an average price of $47.05, potentially reaching $50.02. While $43.04 is the low estimate, the potential upside is significant.
  • Akero Therapeutics Inc (AKRO) stock is expected to climb by 2050, reaching an average of $27.94, a $-9.80% jump from its current level. However, a wide range of estimates exists, with high and low targets of $31.70 and $12.40, respectively, highlighting the market's uncertainty.

Akero Therapeutics Inc Stock (AKRO) Year by Year Forecast

Akero Therapeutics Inc Stock (AKRO) Price Forecast for 2024

Our forecast for AKRO stock price in 2024 now indicates an average price target of $26.16 with a high forecast of $37.00 and a low forecast of $15.32. The average prediction reflects an decrease of -15.56% from the last recorded price of $30.98.
Month Average Low High Change from today's price
December, 2024 $20.53 $17.38 $34.28 -33.73%

Akero Therapeutics Inc Stock (AKRO) Price Forecast for 2025

Akero Therapeutics Inc Stock (AKRO) is expected to reach an average price of $26.37 in 2025, with a high prediction of $41.54 and a low estimate of $11.19. This indicates an -14.89% fall from the last recorded price of $30.98.
Month Average Low High Change from today's price
January, 2025 $24.44 $20.05 $27.65 -21.11%
February, 2025 $17.75 $11.19 $26.00 -42.70%
March, 2025 $20.02 $12.91 $22.77 -35.37%
April, 2025 $21.47 $18.98 $24.94 -30.69%
May, 2025 $26.09 $19.96 $26.26 -15.78%
June, 2025 $24.02 $22.90 $27.68 -22.46%
July, 2025 $36.18 $22.48 $41.54 +16.79%
August, 2025 $34.92 $33.23 $38.62 +12.72%
September, 2025 $34.41 $31.81 $38.32 +11.08%
October, 2025 $29.19 $26.78 $38.10 -5.77%
November, 2025 $29.23 $25.46 $30.14 -5.64%
December, 2025 $28.83 $27.10 $31.37 -6.93%

Akero Therapeutics Inc Stock (AKRO) Price Forecast for 2026

The predicted value for Akero Therapeutics Inc (AKRO) in 2026 is set at an average of $26.65. Estimates vary from a peak of $35.25 to a trough of $18.04, indicating an -13.99% surge from the present price of $30.98.
Month Average Low High Change from today's price
January, 2026 $26.18 $25.20 $30.12 -15.49%
February, 2026 $29.80 $23.92 $33.30 -3.80%
March, 2026 $30.78 $29.09 $33.27 -0.64%
April, 2026 $29.39 $27.98 $35.25 -5.13%
May, 2026 $29.34 $26.49 $30.13 -5.29%
June, 2026 $27.30 $26.14 $32.87 -11.87%
July, 2026 $28.02 $25.53 $30.91 -9.55%
August, 2026 $22.71 $21.72 $28.74 -26.69%
September, 2026 $21.26 $18.04 $24.36 -31.37%
October, 2026 $25.41 $21.41 $25.74 -17.97%
November, 2026 $22.54 $22.06 $26.40 -27.23%
December, 2026 $26.62 $20.68 $27.09 -14.06%

Akero Therapeutics Inc Stock (AKRO) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Akero Therapeutics Inc (AKRO) is $19.03, with a high forecast of $30.16 and a low forecast of $7.9045. This indicates an -38.56% decrease from the last price of $30.98.
Month Average Low High Change from today's price
January, 2027 $21.64 $20.39 $27.36 -30.14%
February, 2027 $22.33 $19.79 $22.78 -27.91%
March, 2027 $16.89 $16.08 $22.97 -45.47%
April, 2027 $18.12 $16.86 $20.81 -41.50%
May, 2027 $14.59 $14.37 $19.86 -52.89%
June, 2027 $14.25 $13.10 $16.49 -53.99%
July, 2027 $11.54 $10.43 $14.64 -62.74%
August, 2027 $9.0244 $8.2644 $11.52 -70.87%
September, 2027 $9.8345 $7.9045 $13.36 -68.26%
October, 2027 $11.19 $10.12 $12.61 -63.87%
November, 2027 $12.42 $10.38 $14.49 -59.90%
December, 2027 $26.40 $10.86 $30.16 -14.77%

Akero Therapeutics Inc Stock (AKRO) Price Forecast for 2028

In 2028, Akero Therapeutics Inc (AKRO) is projected to reach an average price of $42.18, with a high projection of $58.77 and a low estimate of $25.59. This indicates an +36.15% rise from the last price of $30.98.
Month Average Low High Change from today's price
January, 2028 $38.88 $25.59 $40.87 +25.51%
February, 2028 $38.87 $37.59 $45.70 +25.45%
March, 2028 $45.85 $37.27 $48.63 +47.98%
April, 2028 $55.19 $36.19 $55.22 +78.13%
May, 2028 $49.89 $43.02 $55.27 +61.02%
June, 2028 $42.22 $41.89 $50.70 +36.26%
July, 2028 $40.62 $38.45 $48.79 +31.10%
August, 2028 $46.69 $35.75 $47.80 +50.69%
September, 2028 $45.99 $43.13 $50.23 +48.43%
October, 2028 $52.66 $43.14 $54.47 +69.96%
November, 2028 $45.96 $43.14 $58.77 +48.34%
December, 2028 $43.92 $41.13 $47.22 +41.75%

Akero Therapeutics Inc Stock (AKRO) Price Forecast for 2029

The 2029 price forecast for Akero Therapeutics Inc Stock (AKRO) is $32.90 on average, with a high prediction of $54.16 and a low estimate of $11.64. This represents an +6.18% increase from the previous price of $30.98.
Month Average Low High Change from today's price
January, 2029 $50.13 $42.02 $52.19 +61.80%
February, 2029 $50.97 $45.34 $54.16 +64.51%
March, 2029 $11.77 $11.64 $51.63 -62.02%
April, 2029 $16.01 $11.75 $16.05 -48.33%
May, 2029 $23.30 $15.87 $23.72 -24.80%
June, 2029 $22.83 $21.71 $25.30 -26.32%
July, 2029 $21.20 $20.35 $24.03 -31.58%
August, 2029 $28.20 $15.71 $30.86 -8.98%
September, 2029 $25.65 $23.96 $37.39 -17.22%
October, 2029 $20.28 $18.59 $25.68 -34.55%
November, 2029 $19.94 $16.82 $22.70 -35.64%
December, 2029 $24.96 $16.84 $27.63 -19.43%

Akero Therapeutics Inc Stock (AKRO) Price Forecast for 2030

Akero Therapeutics Inc Stock (AKRO) is expected to reach an average price of $23.12 in 2030, with a high forecast of $34.66 and a low forecast of $11.57. This signifies an -25.38% decrease from the last price of $30.98.
Month Average Low High Change from today's price
January, 2030 $28.31 $24.30 $30.95 -8.62%
February, 2030 $20.65 $17.96 $30.59 -33.34%
March, 2030 $21.50 $17.79 $26.73 -30.60%
April, 2030 $21.11 $19.36 $24.66 -31.86%
May, 2030 $21.63 $18.39 $26.25 -30.18%
June, 2030 $19.82 $19.21 $34.66 -36.02%
July, 2030 $27.76 $17.76 $27.92 -10.39%
August, 2030 $25.26 $21.31 $28.03 -18.46%
September, 2030 $22.14 $11.57 $24.97 -28.53%
October, 2030 $21.16 $18.43 $25.32 -31.69%
November, 2030 $24.89 $20.27 $25.75 -19.67%
December, 2030 $27.36 $23.28 $28.06 -11.68%
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
Cap:     |  Volume (24h):